As always, each reader can decide for themselves.
Aldous asserts that SAHPRA is “wilfully blinded to the totality of the evidence follow only what is fed to them by other ‘reputable’ national and international bodies”. After SAHPRA’s decision this week, Aldous penned the following article dissecting Ivermectin trials, which credibly evidence the benefits of Ivermectin. Professor Colleen Aldous, a healthcare scientist at UKZN’s College of Health Sciences, has valiantly challenged the establishment’s resistance to Ivermectin throughout the pandemic. However, when Covid-19 came along, Ivermectin was a thorn in the side of the official narrative. In 2015, the two individuals who developed Ivermectin were awarded a Nobel Prize for medicine.
Prior to the onset of Covid-19, Ivermectin had been used in humans for 35 years and over four billion doses had been administered.
This week, the South African Health Products Regulatory Authority (SAHPRA) announced that: “Given that there is currently no credible evidence to support a therapeutic role for Ivermectin in Covid-19, SAHPRA has decided to terminate the controlled compassionate programme with immediate effect.” SAHPRA enabled the programme in response to the demand for access to Ivermectin for human use, which was initiated at the beginning of 2021, after the country had been under lockdown for almost an entire year and was desperate for alternative therapies to treat Covid-19.
0 kommentar(er)
